Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    "Temporal arteritis"
Show Display Options
RSS Create an RSS feed from your search for:
"Temporal arteritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
2 Not yet recruiting Aetiology of TemporaL Arteritis Study
Condition: Temporal Arteritis
Intervention:
3 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
4 Recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
5 Terminated A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Infliximab
6 Completed Hydroxychloroquine in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: hydroxychloroquine/placebo
7 Unknown  Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Prednisone therapy and pharmacokinetic
8 Completed Tocilizumab for Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Tocilizumab + Glucocorticoids (GCs);   Drug: Placebo + Glucocorticoids (GCs)
9 Recruiting Biomarkers in Giant Cells Arteritis
Condition: Giant Cells Arteritis
Interventions: Behavioral: Clinical evaluation;   Other: Paraclinical evaluation;   Device: Imaging;   Other: Ophthalmologic examination;   Biological: Dosage of biomarkers
10 Not yet recruiting Giant Cell Arteritis and Anakinra Trial
Condition: Giant Cell Arteritis
Interventions: Drug: PLACEBO;   Drug: ANAKINRA
11 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
12 Completed HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: adalimumab;   Drug: placebo
13 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
14 Active, not recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: prednisone;   Drug: prednisone placebo;   Drug: tocilizumab [RoActemra/Actemra];   Drug: tocilizumab placebo
15 Not yet recruiting Ustekinumab for the Treatment of Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Temporal Arteritis;   Horton's Disease
Interventions: Drug: Ustekinumab;   Drug: Prednisone
16 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
17 Completed MRI Superficial Temporal Artery
Condition: Temporal Arteritis
Intervention: Device: MRI
18 Recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
19 Not yet recruiting Polymyalgia Rheumatica and Giant Cell Arteritis
Conditions: Polymyalgia Rheumatica;   Giant Cell Arteritis
Intervention: Other: 18F-FDG PET/CT
20 Completed Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: methotrexate;   Drug: prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.